LB773 Treating pemphigus vulgaris (PV) and foliaceus (PF) by inhibiting the neonatal Fc receptor: Phase 2 multicentre open-label trial with efgartigimod
| Autor: | Goebeler, M., Bata-Csörgo, Z., de Simone, C., Didona, B., Remenyik, E., Reznichenko, N., Schmidt, E., Stoevesandt, J., Ward, E., Parys, W., de Haard, H., Dupuy, P., Verheesen, P., Joly, P. |
|---|---|
| Zdroj: | In Journal of Investigative Dermatology September 2021 141(9):B16-B16 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|